WFRF:(Erfurth Eva Marie)
Search: WFRF:(Erfurth Eva Marie) > (2020-2023) > Diagnosis, Backgrou...
- 3 of 11
- Previous record
- Next record
- To hitlist
Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma
-
- Erfurth, Eva Marie (author)
- Lund University,Lunds universitet,Medicin/akutsjukvård, Lund,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Infektionsmedicin,Sektion III,Institutionen för kliniska vetenskaper, Lund,Endokrin,Forskargrupper vid Lunds universitet,Medicine, Lund,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Infection Medicine (BMC),Section III,Department of Clinical Sciences, Lund,Endocrine,Lund University Research Groups,Skåne University Hospital
- (creator_code:org_t)
- 2020-06-24
- 2020
- English.
- In: Neuroendocrinology. - : S. Karger AG. - 0028-3835 .- 1423-0194. ; 110:9-10, s. 767-779
- Research review (peer-reviewed)
Abstract
Subject headings
Close
- Craniopharyngiomas (CP) are rare brain tumors managed primarily with surgery and radiotherapy. There are 2 phenotypes of CP, i.e., one with a rather good outcome without hypothalamic damage and another with hypothalamic damage. With hypothalamic damage, progressive disease with recurrent operations and additional cranial radiotherapy often result in hypothalamic obesity, an affected psychosocial life, and cognitive dysfunction. The morbidity and mortality are increased for particularly cerebrovascular diseases. Preoperative hypothalamic involvement to predict hypothalamic damage is important for decision making for hypothalamus-sparing surgery. Also a postoperative hypothalamic damage evaluation with the use of hypothalamus volume measurement can predict hypothalamic obesity, which is important for early treatment options. The morbidity of CP includes cognitive dysfunction with attention deficits and impaired episodic memory and processing speed. Again patients with hypothalamic damage are more affected. Treatment options of hypothalamic obesity in the chronic phase are scarce and not convincingly successful. The most optimal situation is to try to hinder or stop the evolution of hypothalamic obesity. Prevention of hypothalamic damage is recommended, with special regard to hypothalamus-sparing therapeutic approaches that respect the integrity of essential nuclei located in both the medial and the posterior hypothalamic areas.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Keyword
- Craniopharyngioma
- Hypothalamic obesity
- Hypothalamus
- Neurosurgery
Publication and Content Type
- for (subject category)
- ref (subject category)
Find in a library
- Neuroendocrinology (Search for host publication in LIBRIS)
To the university's database
- 3 of 11
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Erfurth, Eva Mar ...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Neurology
- Articles in the publication
- Neuroendocrinolo ...
- By the university
- Lund University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
